CAS: 1233322-09-2
Marchio | Dati del prodotto | Purezza | Fascia di prezzo | Consegna prevista |
---|---|---|---|---|
BI-69A11 REF: TM-T25150CAS: 1233322-09-2 | 96.97% | 45,00 €~361,00 € | Ven 25 Ott 24 | |
(E)-3-(1H-Benzo[d]imidazol-2-yl)-1-(6-chloro-2-hydroxy-4-phenylquinolin-3-yl)prop-2-en-1-one REF: 3D-IZB32209CAS: 1233322-09-2 | Min. 95% | Prezzo su richiesta | Ven 29 Nov 24 |
BI-69A11
CAS:1233322-09-2
BI-69A11 is a dual AKT/NFkB inhibitor, increasing colon cancer cell sensitivity to mda-7/IL-24.
Formula:
C25H16ClN3O2
Purezza:
96.97%
Colore e forma:
Solid
Peso molecolare:
425.87
Ref: TM-T25150
1mg | 45,00 € | ||
1ml | 92,00 € | ||
2mg | 56,00 € | ||
5mg | 81,00 € | ||
10mg | 94,00 € | ||
25mg | 177,00 € | ||
50mg | 253,00 € | ||
100mg | 361,00 € |
Consegna stimata in Stati Uniti, il Venerdì 25 Ottobre 2024
(E)-3-(1H-Benzo[d]imidazol-2-yl)-1-(6-chloro-2-hydroxy-4-phenylquinolin-3-yl)prop-2-en-1-one
CAS:1233322-09-2
(E)-3-(1H-Benzo[d]imidazol-2-yl)-1-(6-chloro-2-hydroxy-4-phenylquinolin-3-yl)prop-2-en-1-one is a novel anticancer drug that is currently undergoing clinical trials. It has been …
Formula:
C25H16ClN3O2
Purezza:
Min. 95%
Peso molecolare:
425.9 g/mol
Ref: 3D-IZB32209
50mg | Prezzo su richiesta | ||
100mg | Prezzo su richiesta |
Consegna stimata in Stati Uniti, il Venerdì 29 Novembre 2024